Acceptance and Commitment Therapy for Depression in Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This randomized controlled trial aims to assess effects of videoconferencing acceptance and commitment therapy (ACT) on mental health outcomes in individuals living with spinal cord injuries (SCI). A total of 34 individuals living with SCI sustained within 5 years and experiencing depressive symptoms will be recruited and randomly assigned to either the ACT group or the wait-list control group. The ACT group will receive 8 weekly individual ACT sessions guided by a coach through videoconferencing. The wait-list group will receive ACT sessions after the study period ends. We will provide psychoeducation materials related to SCI as supplemental resources to both groups. Mental health outcomes using self-reported questionnaires will be collected at pretest, posttest, and 2-month follow-up. Exploratory hypotheses are that the group undergoing the ACT intervention supplemented with psychoeducation will show improvements in mental health outcomes (e.g., depression) and ACT processes (e.g., psychological flexibility) at posttest and 2-month follow-up, compared to the wait-list control group provided with psychoeducation materials alone. Interviews will be conducted at posttest to explore the participants' experiences in ACT.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue them, but please confirm with the study coordinators.
What data supports the idea that Acceptance and Commitment Therapy for Depression in Spinal Cord Injury is an effective treatment?
The available research shows that Acceptance and Commitment Therapy (ACT) can help reduce depressive symptoms in people with spinal cord injuries. One study found that ACT processes are linked to fewer depressive symptoms and less pain interference in these individuals. Another study demonstrated that ACT is effective in treating depression in people with physical disabilities, which includes those with spinal cord injuries. Additionally, a study using videoconferencing ACT with psychoeducation showed positive effects on distressed individuals with spinal cord injuries. These findings suggest that ACT can be a helpful treatment for depression in this group.12345
What safety data exists for Acceptance and Commitment Therapy (ACT) for depression in spinal cord injury?
The provided research does not explicitly mention safety data for Acceptance and Commitment Therapy (ACT) in the context of depression in spinal cord injury. The studies focus on the effectiveness and core processes of ACT, its impact on depressive symptoms, anxiety, stress, and PTSD in individuals with spinal cord injury. However, none of the abstracts specifically address safety concerns or adverse effects related to ACT.12367
Is Acceptance and Commitment Therapy a promising treatment for depression in people with spinal cord injury?
Research Team
Areum Han, PhD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults over 18 who have had a spinal cord injury in the last 5 years and are experiencing mild depression. Participants need to have internet access, a computer or smartphone at home. It's not for those with cognitive deficits, language barriers that could affect participation, recent suicidal attempts, or previous ACT therapy experience.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weekly individual ACT sessions guided by a coach through videoconferencing
Follow-up
Participants are monitored for mental health outcomes using self-reported questionnaires at posttest and 2-month follow-up
Treatment Details
Interventions
- Acceptance and Commitment Therapy
- Wait-list Control Group with Psychoeducation Materials Provided
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Paralyzed Veterans of America
Collaborator